Tudor Investment Corp’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-26,634	Closed	-$59.7K	–	2044
2024 Q2	$59.7K	Buy	+26,634	New	+$59.7K	﹤0.01%	1424
2020 Q4	–	Sell	-9,725	Closed	-$218K	–	1615
2020 Q3	$218K	Buy	+9,725	New	+$218K	0.01%	1109